Related Experiment Videos

Molecular cloning of the complementary DNA for human tumor necrosis factor

Science (New York, N.Y.)
|April 12, 1985
PubMed

Insights

Researchers purified and cloned human tumor necrosis factor (TNF), a protein that selectively damages tumor cells. This work enables further study and potential therapeutic applications of TNF.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Immunology

Background:

  • Tumor necrosis factor (TNF) is a protein with selective toxicity to tumor cells.
  • Understanding TNF's properties is crucial for cancer research.

Purpose of the Study:

  • To purify human TNF from leukemia cells.
  • To determine its amino acid sequence and clone the corresponding cDNA.
  • To achieve high-level expression of TNF in bacteria.

Main Methods:

  • Protein purification from HL-60 leukemia cells.
  • Amino acid sequencing of the N-terminus.
  • cDNA cloning using synthesized oligonucleotide probes.
  • Nucleotide sequence analysis.
  • Expression in E. coli using lambda PL promoter.

Main Results:

  • Human TNF was purified as a 17.3-kDa protein with cytotoxic and cytostatic activity.
  • The amino acid sequence of the N-terminus was determined.
  • Human TNF cDNA (1585 bp) encoding 233 amino acids was cloned.
  • Mature TNF starts at residue 77, with a 76-amino acid leader sequence.
  • High-level expression of TNF in E. coli was achieved.

Conclusions:

  • Successful purification and characterization of human TNF.
  • Cloning of human TNF cDNA provides a tool for further research.
  • Engineered E. coli system allows for large-scale TNF production.

Related Concept Videos